Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,352 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles.
Minami T, Matsueda S, Takedatsu H, Tanaka M, Noguchi M, Uemura H, Itoh K, Harada M. Minami T, et al. Among authors: uemura h. Cancer Immunol Immunother. 2007 May;56(5):689-98. doi: 10.1007/s00262-006-0216-9. Epub 2006 Aug 26. Cancer Immunol Immunother. 2007. PMID: 16937115 Free PMC article.
Telomerase activity in primary prostate cancer.
Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M, Kubota Y. Lin Y, et al. Among authors: uemura h. J Urol. 1997 Mar;157(3):1161-5. J Urol. 1997. PMID: 9072562
Detection of telomerase activity in prostate needle-biopsy samples.
Lin Y, Uemura H, Fujinami K, Hosaka M, Iwasaki Y, Kitamura H, Harada M, Kubota Y. Lin Y, et al. Among authors: uemura h. Prostate. 1998 Jul 1;36(2):121-8. doi: 10.1002/(sici)1097-0045(19980701)36:2<121::aid-pros7>3.0.co;2-l. Prostate. 1998. PMID: 9655264
A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.
Noguchi M, Kakuma T, Uemura H, Nasu Y, Kumon H, Hirao Y, Moriya F, Suekane S, Matsuoka K, Komatsu N, Shichijo S, Yamada A, Itoh K. Noguchi M, et al. Among authors: uemura h. Cancer Immunol Immunother. 2010 Jul;59(7):1001-9. doi: 10.1007/s00262-010-0822-4. Epub 2010 Feb 10. Cancer Immunol Immunother. 2010. PMID: 20146063 Free PMC article. Clinical Trial.
Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination.
Noguchi M, Mine T, Komatsu N, Suekane S, Moriya F, Matsuoka K, Yutani S, Shichijo S, Yamada A, Toh U, Kawano K, Azuma K, Uemura H, Okuno K, Matsumoto K, Yanagimoto H, Yamanaka R, Oka M, Todo S, Sasada T, Itoh K. Noguchi M, et al. Among authors: uemura h. Cancer Biol Ther. 2010 Dec 15;10(12):1266-79. doi: 10.4161/cbt.10.12.13448. Epub 2010 Dec 15. Cancer Biol Ther. 2010. PMID: 20935522
1,352 results